Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Recent Progress in Cancer Immunotherapy: Application of Nano-Therapeutic Systems Publisher



Ghafelehbashi R1 ; Salehi M2, 3 ; Kouhi M1 ; Alizadehnaini A4 ; Sajadijavan ZS5 ; Nejatidanesh F1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Dental Materials Research Center, Dental Research Institute, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran
  2. 2. Clinical Research Development Unit, Booalisina Hospital, Qazvin University of Medical Sciences, Qazvin, Iran
  3. 3. Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran
  4. 4. Department of Materials Science and Engineering, School of Engineering, Shiraz University, Shiraz, Iran
  5. 5. Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran

Source: Journal of Drug Delivery Science and Technology Published:2024


Abstract

Cancer immunotherapy is a hopeful strategy that seeks to enhance the immune system's capacity to detect, manage, and eradicate cancerous cells. It has shown promise in halting the dissemination of tumor cells via the bloodstream and impeding micro-metastases in remote organs. The primary techniques for cancer immunotherapy involve utilizing tumor-specific antibodies and immune effector cells. Researches are being conducted on nanoparticle-based therapeutic systems as an alternative to immunosuppressive drugs, which have poor immunogenicity and side effects. These systems have immunomodulatory agents that activate immune cells and modify the tumor microenvironment, leading to enhanced antitumor immunity. This review provides an overview of the latest developments in cancer nanoimmunotherapy, including the mechanisms of action and applications of various organic and inorganic nanoparticles (such as liposomes, polysaccharides, synthetic polymers, iron oxide, gold, and black phosphorous), as well as nanocomposite hydrogels, nanogels, and emulsions. The review also explores the emerging field of stimuli-responsive nanotherapeutics in cancer immunotherapy. Finally, the clinical applications, future prospects, and challenges of nanotherapeutic systems in cancer immunotherapy are discussed. © 2023 Elsevier B.V.
Other Related Docs
24. Oncolytic Virotherapy Improves Immunotherapies Targeting Cancer Stemness in Glioblastoma, Biochimica et Biophysica Acta - General Subjects (2024)